Chru de Brest Hopital Cavale Blanche

Brest 29200

1 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Adenocarcinoma, Metastatic Gastric Adenocarcinoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed